title: What's new in the field of prostate cancer chemoprevention?
abstract: Chemoprevention trials for several malignancies are completed, planned, or underway. Prostate cancer is one of the most common forms of cancer and understandably has received considerable recent attention as a potential target for chemoprevention. This article examines chemoprevention trials for prostate cancer, including the Prostate Cancer Prevention Trial, Selenium and Vitamin E Cancer Prevention Trial, and cyclooxygenase inhibitors in the prevention of prostate cancer.
authors.affiliation: Division of Urology, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA.
authors.forename: Kanwaljit
authors.initials: K
authors.lastname: Mahal
authors.forename: Javier
authors.initials: J
authors.lastname: Hernandez
authors.forename: Joseph W
authors.initials: JW
authors.lastname: Basler
authors.forename: Ian M
authors.initials: IM
authors.lastname: Thompson
mesh_terms: D000975:Antioxidants / Q000627:therapeutic use; D018890:Chemoprevention / Q000379:methods / Q000639:trends*; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000517:prevention & control*; D012643:Selenium / Q000627:therapeutic use; D014810:Vitamin E / Q000627:therapeutic use
chemical_list: D000975:Antioxidants; D016861:Cyclooxygenase Inhibitors; D014810:Vitamin E; D012643:Selenium